SlimShot for Ozempic Mounjaro
SlimShot is a health tracking app for patients on GLP-1 medications, providing medication reminders and symptom logs on iOS and Android.
The App DNA
What makes this app unique?
It removes the cognitive friction of tracking complex injection schedules and side effects, a task that generic calorie trackers do not address.
For Patients prescribed GLP-1 receptor agonists like Ozempic or Mounjaro seeking to track medication adherence and lifestyle changes.
What does it look like?
Key features
Scheduled push notifications for Semaglutide and Tirzepatide dosing. Revenue link: Daily notification loop reinforces app habit, increasing DAU/MAU ratio and retention.
Manual input fields for daily water intake and food consumption. Revenue link: High-frequency logging requirement drives session count, expanding potential ad-inventory.
Aggregated tracking data formatted for review by healthcare providers. Revenue link: Utility as a clinical record tool increases switching cost, acting as a direct retention lever.
Logbook for recording side effects or physical responses to medication. Revenue link: Specialized health data collection creates a niche utility, differentiating the product from generic trackers.
How much does it cost?
Freemium model utilizing in-app purchases to monetize a specialized health tracking utility.
Velocity
Maintenance developmentperformanceopaqueShow more...
The app maintains a maintenance-level cadence, shipping only one release in the observed window. With the latest update occurring 50 days ago, development is focused exclusively on minor bug fixes rather than new content or feature expansion. The release notes remain generic, providing no indication of a shift toward live operations or significant feature development. The current pace suggests a stable but minimal support cycle.
Who built it?
SPOKEN TECHNOLOGIES
3 apps tracked · Health & Fitness
eProfit - Sell on ebay with AI
eProfit - Sell on ebay with AIUser Sentiment
What do users think recently?
Fresh user feedback skews mixed. Users appreciate simple and focused feature set helps users track their weight loss journey without unnecessary complexity and medication reminder functionality provides a reliable way for users to stay on track with their doses, but report forced review prompts before users can access the app create a negative first impression and frustration.
How are ratings & reviews evolving?
What users say, by theme
- Simple and focused feature set helps users track their weight loss journey without unnecessary complexity
- Medication reminder functionality provides a reliable way for users to stay on track with their doses
- Forced review prompts before users can access the app create a negative first impression and frustration
50 of 50 recent reviews analyzed · high confidence · Mixed overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for SlimShot for Ozempic Mounjaro
How's the Health & Fitness market?
SlimShot occupies a niche within the Health & Fitness category, targeting a specific GLP-1 patient segment. The current 4.7-star rating across 1,738 total ratings suggests strong product-market fit for the core utility, though the 50-review sample indicates a small active user base.
The rivals identified
The Analyst's Read
Key takeaways for SlimShot for Ozempic Mounjaro
Where is it heading?
The market for GLP-1 tracking is expanding, but SlimShot is currently stalled by maintenance-mode development and high-friction onboarding. Addressing technical stability and localization is necessary to prevent users from migrating to more stable, globally-accessible alternatives.
- Forced review prompts create a negative first impression, which suppresses organic growth and creates a long-term churn risk.
- Technical instability in the latest release hinders basic tracking tasks, eroding the daily habit required for medication adherence.
The SWOT
- Specialized medication reaction logbook creates a niche utility barrier
- Medication reminders reinforce daily habit and retention
- Localized metric units would capture the international user segment
Next best moves
Sunset the forced review gate because it is the primary driver of negative sentiment and churn → improve first-impression conversion
+ 2 more prioritized movesThe counter-intuitive read
Users report: The high store rating is a liability…
Read the full takeBottom line
Removing the forced review gate would immediately address the primary churn driver, allowing the core medication-tracking utility to retain users based on its clinical value rather than artificial friction.
Unlock 2 critical frictions, 1 market threat, 2 more prioritized moves and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing
Report last updated